Reported Tuberculosis in the United States, 2020
Table 17. National Tuberculosis Genotyping Surveillance Coverage:1 United States-Affiliated Areas,2 2004–2020
Year | Reported TB Cases | Reported Culture-Positive Cases | Cases with Genotype Result | Genotype Surveillance Coverage |
---|---|---|---|---|
No. | No. | No. | (%) | |
2004 | 288 | 213 | 19 | (8.9) |
2005 | 388 | 237 | 95 | (40.1) |
2006 | 344 | 211 | 84 | (39.8) |
2007 | 527 | 181 | 85 | (47.0) |
2008 | 553 | 240 | 73 | (30.4) |
2009 | 534 | 237 | 206 | (86.9) |
2010 | 618 | 310 | 279 | (90.0) |
2011 | 463 | 230 | 193 | (83.9) |
2012 | 493 | 248 | 225 | (90.7) |
2013 | 421 | 230 | 208 | (90.4) |
2014 | 468 | 237 | 221 | (93.2) |
2015 | 413 | 148 | 135 | (91.2) |
2016 | 506 | 226 | 208 | (92.0) |
2017 | 531 | 254 | 238 | (93.7) |
2018 | 637 | 203 | 182 | (89.7) |
2019 | 491 | 192 | 179 | (93.2) |
2020 | 372 | 162 | 142 | (87.7) |
1Genotype surveillance coverage is defined as the percentage of all culture-positive tuberculosis (TB) cases for which there was a genotyped isolate.
2The U.S.-affiliated areas include: American Samoa, Commonwealth of the Northern Mariana Islands, Federated States of Micronesia, Guam, Republic of the Marshall Islands, Republic of Palau, Puerto Rico, and U.S. Virgin Islands.